Oklo (NYSE:OKLO) continued to invest in its pre-commercial nuclear technology during Q3, achieving several operational and regulatory milestones.
Oklo completed Phase 1 of its Nuclear Regulatory Commission (NRC) readiness assessment with no significant gaps and expects to file its Aurora combined license application in early Q4 2025.
The company reaffirmed its target for commercial operations of the first Aurora powerhouse in late 2027 to early 2028.
Oklo recorded no revenue during the Q3 period, consistent with its ongoing development stage.
Its loss per share was $0.20, up from a loss per share of $0.08 in the year-ago period and more than the $0.14 loss per share expected by Wall Street analysts.
Year-to-date cash used in operating activities was $48.7 million, below the company’s full-year forecast of $65 million to $80 million.
Shares of Oklo traded down 1.7% at $102.50 post-earnings. The stock has surged 390% so far in 2025.